Reliance Life Sciences

Biopharmaceutical company in the Reliance group making biosimilars, specialty pharmaceuticals and plasma proteins. Holds an active US Drug Master File for liraglutide API, filed in 2026.

Directory assessment: Reliance Life Sciences is listed as a manufacturer in the peptide supply chain, serving Asia markets from India (Navi Mumbai). As a direct manufacturer, this supplier controls its own production process from synthesis through purification and quality control release testing. This profile lists 2 sources for reference. This supplier has a medium confidence score — verification signals are present, but the listing is newer or less documented; perform standard due diligence before engaging.